Article Data

  • Views 403
  • Dowloads 70

Original Research

Open Access

Features of Neurovascular Orofacial Pain Compared to Painful Posttraumatic Trigeminal Neuropathy

  • Yaron Haviv1,*,
  • Avraham Zini2
  • Naama Keshet1
  • Galit Almoznino3
  • Rafael Benoliel4
  • Yair Sharav1

1Department of Oral Medicine, School of Dental Medicine, Hebrew University-Hadassah, Jerusalem, Israel

2Department of Community Dentistry, School of Dental Medicine, Hebrew University-Hadassah, Jerusalem, Israel

3Department of Oral Medicine, Department of Community Dentistry, School of Dental Medicine, Hebrew University-Hadassah, Jerusalem, Israel

4Department of Diagnostic Sciences, Rutgers School of Dental Medicine, Rutgers State University of New Jersey, Newark, New Jersey, USA

DOI: 10.11607/ofph.2448 Vol.34,Issue 2,June 2020 pp.121-128

Submitted: 20 January 2019 Accepted: 10 May 2019

Published: 30 June 2020

*Corresponding Author(s): Yaron Haviv E-mail: yaron.haviv@gmail.com

Abstract

Aims: To test and re-examine the diagnostic criteria for neurovascular orofacial pain (NVOP) compared to posttraumatic trigeminal neuropathy (PTTN). Methods: Pain and patient characteristics were compared in patients with NVOP, PTTN, and NVOP initiated by trauma (PT-NVOP). NVOP criteria were based on prior studies, and PTTN was defined according to the International Classification of Headache Disorders, version 3 beta. Results: Of the 170 patients in the cohort, 90 had PTTN, 51 had NVOP, and 29 had PT-NVOP. None of the tested parameters in the NVOP and PT-NVOP patients were significantly different, and therefore these patients were combined into one group (T-NVOP). T-NVOP differed significantly from PTTN (P < .001) in periodic pain patterns, presence of autonomic and systemic signs, throbbing pain quality, and frequency of bilaterality. Pain quality in PTTN was more burning/stabbing than in NVOP (P = .003). Pain severity, waking from sleep, muscle sensitivity to palpation, and demographics were comparable. Conclusion: NVOP differs from PTTN in parameters essential to diagnosis: periodicity of pain, presence of autonomic and systemic accompanying signs, throbbing pain quality, and bilateral presentation. NVOP is amenable to abortive and prophylactic antimigraine therapies, distinguishing NVOP from PTTN in clinical features, treatment, and prognosis.

Keywords

migraine; neurovascular orofacial pain; persistent idiopathic facial pain; post traumatic trigeminal neuropathy

Cite and Share

Yaron Haviv,Avraham Zini,Naama Keshet,Galit Almoznino,Rafael Benoliel,Yair Sharav. Features of Neurovascular Orofacial Pain Compared to Painful Posttraumatic Trigeminal Neuropathy . Journal of Oral & Facial Pain and Headache. 2020. 34(2);121-128.

References

1. Sharav Y, Haviv Y, Almoznino G, Benoliel R. Neurovascular orofacial pain. In: Farah CS, Balasubramaniam R, McCullough M (eds). Contemporary Oral Medicine. Switzerland: Springer, 2017:1–22.

2. Peñarrocha M, Bandrés A, Peñarrocha M, Bagán JV. Lower-half facial migraine: A report of 11 cases. J Oral Maxillofac Surg 2004;62:1453–1456.

3. Daudia AT, Jones NS. Facial migraine in a rhinological setting. Clin Otolaryngol Allied Sci 2002;27:521–525.

4. Gaul C, Sándor PS, Galli U, Palla S, Ettlin DA. Orofacial migraine. Cephalalgia 2007;27:950–952.

5. Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition. Cephalalgia 2018;38:1–211.

6. Cademartiri C, Torelli P, Cologno D, Manzoni GC. Upper and lower cluster headache: Clinical and pathogenetic observations in 608 patients. Headache 2002;42:630–637.

7. Gaul C, Gantenbein AR, Buettner UW, Ettlin DA, Sándor PS. Orofacial cluster headache. Cephalalgia 2008;28:903–905.

8. Cohen AS, Matharu MS, Goadsby PJ. Short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT) or cranial autonomic features (SUNA)—A prospective clinical study of SUNCT and SUNA. Brain 2006;129:2746–2760.

9. Goadsby PJ, Cittadini E, Cohen AS. Trigeminal autonomic cephalalgias: Paroxysmal hemicrania, SUNCT/SUNA, and hemicrania continua. Semin Neurol 2010;30:186–191.

10. Czerninsky R, Benoliel R, Sharav Y. Odontalgia in vascular orofacial pain. J Orofac Pain 1999;13:196–200.

11. Eross E, Dodick D, Eross M. The Sinus, Allergy and Migraine Study (SAMS). Headache 2007;47:213–224.

12. Foroughipour M, Sharifian SM, Shoeibi A, Ebdali Barabad N, Bakhshaee M. Causes of headache in patients with a primary diagnosis of sinus headache. Eur Arch Otorhinolaryngol 2011; 268:1593–1596.

13. Kari E, DelGaudio JM. Treatment of sinus headache as migraine: The diagnostic utility of triptans. Laryngoscope 2008;118: 2235–2239.

14. Klapper JA, Klapper A, Voss T. The misdiagnosis of cluster headache: A nonclinic, population-based, Internet survey. Headache 2000;40:730–735.

15. Perry BF, Login IS, Kountakis SE. Nonrhinologic headache in a tertiary rhinology practice. Otolaryngol Head Neck Surg 2004;130:449–452.

16. Schreiber CP, Hutchinson S, Webster CJ, Ames M, Richardson MS, Powers C. Prevalence of migraine in patients with a history of self-reported or physician-diagnosed “sinus” headache. Arch Intern Med 2004;164:1769–1772.

17. Senbil N, Gürer YK, Uner C, Barut Y. Sinusitis in children and adolescents with chronic or recurrent headache: A case-control study. J Headache Pain 2008;9:33–36.

18. Rossi P, Faroni J, Tassorelli C, Nappi G. Diagnostic delay and suboptimal management in a referral population with hemicrania continua. Headache 2009;49:227–234.

19. Van Alboom E, Louis P, Van Zandijcke M, Crevits L, Vakaet A, Paemeleire K. Diagnostic and therapeutic trajectory of cluster headache patients in Flanders. Acta Neurol Belg 2009;109:10–17.

20. Viana M, Tassorelli C, Allena M, Nappi G, Sjaastad O, Antonaci F. Diagnostic and therapeutic errors in trigeminal autonomic cephalalgias and hemicrania continua: A systematic review. J Headache Pain 2013;14:14.

21. Benoliel R, Birman N, Eliav E, Sharav Y. The International Classification of Headache Disorders: Accurate diagnosis of orofacial pain? Cephalalgia 2008;28:752–762.

22. Benoliel R, Elishoov H, Sharav Y. Orofacial pain with vascular-type features. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997;84:506–512.

23. Sharav Y, Katsarava Z, Charles A. Facial presentations of primary headache disorders. Cephalalgia 2017;37:714–719.

24. Sharav Y, Katsarava Z, Benoliel R. Migraine and possible facial variants: Neurovascular orofacial pain. In: Sharav Y, Benoliel R (eds). Orofacial Pain and Headache. Chicago: Quintessence, 2015:319–362.

25. Obermann M, Mueller D, Yoon MS, Pageler L, Diener H, Katsarava Z. Migraine with isolated facial pain: A diagnostic challenge. Cephalalgia 2007;27:1278–1282.

26. Dodick DW. Migraine with isolated facial pain: A diagnostic chal-lenge. Cephalalgia 2007;27:1199–1200.

27. Baad-Hansen L, Benoliel R. Neuropathic orofacial pain: Facts and fiction. Cephalalgia 2017;37:670–679.

28. Haviv Y, Zadik Y, Sharav Y, Benoliel R. Painful traumatic trigeminal neuropathy: An open study on the pharmacotherapeutic response to stepped treatment. J Oral Facial Pain Headache 2014;28:52–60.

29. Jenkins TM, Smart TS, Hackman F, Cooke C, Tan KK. Efficient assessment of efficacy in post-traumatic peripheral neuropathic pain patients: Pregabalin in a randomized, placebo-controlled, crossover study. J Pain Res 2012;5:243–250.

30. Benoliel R, Sharav Y, Eliav E. Neurovascular orofacial pain. J Am Dent Assoc 2010;141:1094–1096.

31. Benoliel R, Eliav E, Sharav Y. Self-reports of pain-related awakenings in persistent orofacial pain patients. J Orofac Pain 2009; 23:330–338.

32. Benoliel R, Birenboim R, Regev E, Eliav E. Neurosensory changes in the infraorbital nerve following zygomatic fractures. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005;99:657–665.

33. Benoliel R, Zadik Y, Eliav E, Sharav Y. Peripheral painful traumatic trigeminal neuropathy: Clinical features in 91 cases and proposal of novel diagnostic criteria. J Orofac Pain 2012;26:49–58.

34. Schiffman E, Ohrbach R, Truelove E, et al. Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) for clinical and research applications: Recommendations of the International RDC/TMD Consortium Network* and Orofacial Pain Special Interest Group. J Oral Facial Pain Headache 2014;28:6–27.

35. Kelman L, Rains JC. Headache and sleep: Examination of sleep patterns and complaints in a large clinical sample of migraineurs. Headache 2005;45:904–910.

36. Neut D, Fily A, Cuvellier JC, Vallée L. The prevalence of triggers in paediatric migraine: A questionnaire study in 102 children and adolescents. J Headache Pain 2012;13:61–65.

37. Sharav Y, Leviner E, Tzukert A, McGrath PA. The spatial distribution, intensity and unpleasantness of acute dental pain. Pain 1984;20:363–370.

38. Benoliel R, Sharav Y. Neurovascular orofacial pain. Cephalalgia 2008;28:199–200.

39. Baad-Hansen L, Pigg M, Ivanovic SE, et al. Chairside intraoral qualitative somatosensory testing: Reliability and comparison between patients with atypical odontalgia and healthy controls. J Orofac Pain 2013;27:165–170.

40. Woda A, Tubert-Jeannin S, Bouhassira D, et al. Towards a new taxonomy of idiopathic orofacial pain. Pain 2005;116:396–406.

41. de Rijk P, Resseguier N, Donnet A. Headache characteristics and clinical features of elderly migraine patients. Headache 2018;58:525–533.

42. Russell MB, Rasmussen BK, Fenger K, Olesen J. Migraine without aura and migraine with aura are distinct clinical entities: A study of four hundred and eighty-four male and female migraineurs from the general population. Cephalalgia 1996;16:239–245.

43. Benoliel R, Gaul C. Persistent idiopathic facial pain. Cephalalgia 2017;37:680–691.

44. Harrison SD, Balawi SA, Feinmann C, Harris M. Atypical facial pain: A double-blind placebo-controlled crossover pilot study of subcutaneous sumatriptan. Eur Neuropsychopharmacol 1997;7:83–88.

45. Yoon MS, Mueller D, Hansen N, et al. Prevalence of facial pain in migraine: A population-based study. Cephalalgia 2010;30:92–96.

46. Campbell JK. Manifestations of migraine. Neurol Clin 1990;8: 841–855.

47. Rasmussen BK, Jensen R, Olesen J. A population-based analysis of the diagnostic criteria of the International Headache Society. Cephalalgia 1991;11:129–134.

48. Rasmussen BK, Olesen J. Migraine with aura and migraine without aura: An epidemiological study. Cephalalgia 1992;12:221–228.

49. Natoli JL, Manack A, Dean B, et al. Global prevalence of chronic migraine: A systematic review. Cephalalgia 2010;30:599–609.

50. Stewart WF, Wood C, Reed ML, Roy J, Lipton RB, AMPP Advisory Group. Cumulative lifetime migraine incidence in women and men. Cephalalgia 2008;28:1170–1178.

51. Haviv Y, Khan J, Zini A, Almoznino G, Sharav Y, Benoliel R. Trigeminal neuralgia (part I): Revisiting the clinical phenotype. Cephalalgia 2016;36:730–746.

52. Bartsch T, Knight YE, Goadsby PJ. Activation of 5-HT(1B/1D) receptor in the periaqueductal gray inhibits nociception. Ann Neurol 2004;56:371–381.

53. Kemp WJ 3rd, Tubbs RS, Cohen-Gadol AA. The innervation of the cranial dura mater: Neurosurgical case correlates and a review of the literature. World Neurosurg 2012;78:505–510.

Abstracted / indexed in

Science Citation Index (SCI)

Science Citation Index Expanded (SCIE)

BIOSIS Previews

Scopus

Cumulative Index to Nursing and Allied Health Literature (CINAHL)

Submission Turnaround Time

Conferences

Top